Altay Aliyev

Specialization: Clinical oncologist
16 years of experience
Speaks:
Azerbaijani, English, Turkish
Online consultations: available
Workplace: Azerbaijan, Baku, Liv Bona Dea Hospital Baku
Dr. Altay Aliyev Internal Diseases and Medical Oncology

Explore package deals with Dr. Altay Aliyev

Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Hipertermik İntraperitoneal Kemoterapi (Hyperthermic intraperitoneal chemotherapy)

$7,400

per package

The package includes a standard range of medical services offered by the clinic and additional benefits like accommodation, transfer, etc.

Online consultation with Altay Aliyev

Convenient and easy

100% secure and confidential

Price on request

4.7

Excellent score

1 patient verified reviews

1 star

2 stars

3 stars

4 stars

5 stars

100%

Patient reviews

About clinic Liv Bona Dea Hospital Baku

This doctor doesn’t have reviews, but you can check reviews for the clinic they work at.

Your trust is our top concern

We value your trust above all, so clinics can't pay to alter or remove reviews.

Learn more about reviews.

1-1 of 1 review

Client • Bladder cancer

Kazakhstan

Jul 29, 2024

Verified review.

Thank you very much to the doctor who operated on us

Thank you very much to the doctor who operated on us.

Doctor's services

How are we doing?

1 of 3

Information about this doctor is full and clear

Strongly disagree

Strongly agree

Qualifications

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr 18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery. • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations